If you can detect it, you can treat it.
The hemoglobin A1C diabetes test provides an average of all blood glucose levels over two to three months – invaluable information, to be sure. But it doesn’t show postprandial spikes, which can affect 40% of patients who otherwise appear to have their diabetes under control.
The GlycoMark® blood test closes this gap.
GlycoMark is a new generation test that specifically targets glycemic response above the renal threshold over one to two weeks to give you a window on after-meal glucose peaks.
That’s critical information. Information you can use to improve patient care by targeting the spikes with specific treatments. Information that can help prevent dangerous cardiovascular complications in patients who have previously undetected postprandial serum glucose spikes.
Information you never had before.
